Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023

SELL
$191.51 - $216.16 $504,628 - $569,581
-2,635 Reduced 0.68%
383,687 $81.4 Million
Q2 2023

Jul 31, 2023

SELL
$187.64 - $206.25 $11.4 Million - $12.6 Million
-61,012 Reduced 13.64%
386,322 $74.4 Million
Q1 2023

Apr 27, 2023

SELL
$127.59 - $203.08 $1,148 - $1,827
-9 Reduced -0.0%
447,334 $90.6 Million
Q4 2022

Jan 30, 2023

SELL
$117.37 - $139.17 $1.29 Million - $1.53 Million
-10,975 Reduced 2.39%
447,343 $57.5 Million
Q3 2022

Oct 21, 2022

SELL
$135.27 - $180.11 $211,562 - $281,692
-1,564 Reduced 0.34%
458,318 $62.7 Million
Q2 2022

Jul 26, 2022

BUY
$108.81 - $179.33 $1.26 Million - $2.08 Million
11,604 Added 2.59%
459,882 $81.4 Million
Q1 2022

Apr 27, 2022

SELL
$119.61 - $157.85 $1.96 Million - $2.58 Million
-16,358 Reduced 3.52%
448,278 $64.6 Million
Q4 2021

Feb 02, 2022

BUY
$142.57 - $190.86 $6.49 Million - $8.68 Million
45,499 Added 10.86%
464,636 $71.8 Million
Q3 2021

Oct 25, 2021

SELL
$142.45 - $169.82 $3.29 Million - $3.92 Million
-23,076 Reduced 5.22%
419,137 $71.2 Million
Q2 2021

Aug 02, 2021

SELL
$135.08 - $161.1 $243,144 - $289,980
-1,800 Reduced 0.41%
442,213 $69.8 Million
Q1 2021

Apr 30, 2021

SELL
$137.51 - $190.8 $17.2 Million - $23.8 Million
-124,989 Reduced 21.97%
444,013 $61.7 Million
Q4 2020

Feb 05, 2021

BUY
$164.63 - $211.93 $93.7 Million - $121 Million
569,002 New
569,002 $99.7 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.